Table 2 The prevalence of hyperuricemia among donors and recipients
Men | Women | P value | |||
|---|---|---|---|---|---|
HU | Not HU | HU | Not HU | ||
Donors before donation | 4 | 12 | 1 | 28 | 0.03* |
Donors after donation | 4 | 12 | 2 | 27 | 0.09 |
Recipients after Tx | 5 | 20 | 7 | 13 | 0.26 |
Recipients after Tx, including those who were prescribed XO inhibitors | 17 | 20 | 11 | 13 | 0.99 |